Relationship and Attachment to Digital Health Technology During Cancer Treatment.

Attachment Cancer Digital health Family caregivers Interpretative phenomenology Symptom management

Journal

Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688

Informations de publication

Date de publication:
10 Feb 2024
Historique:
received: 05 05 2023
revised: 06 12 2023
accepted: 15 01 2024
medline: 12 2 2024
pubmed: 12 2 2024
entrez: 11 2 2024
Statut: aheadofprint

Résumé

The aim of this study is to explore the relationship that people with cancer and their family caregivers develop with symptom management technology during chemotherapy. A longitudinal and multi-perspective interpretative phenomenological approach was adopted. Data were collected using one-to-one in-depth interviews with people with colorectal cancer using supportive digital health symptom management technology (n=3) and their family caregivers (n=4) at two time points during chemotherapy treatment. Data were analyzed using interpretative phenomenological analysis and followed COREQ guidelines. People with cancer and their family caregivers can develop emotional bonds with supportive symptom management technology during cancer treatment. Digital health technology can be experienced as a person guiding them during their cancer treatment. Participants felt vulnerable after the technology was returned to the research team. Participants recognized that it was not the technology that successfully facilitated them through their initial chemotherapy cycles; rather, the technology helped them learn to manage their symptoms and promoted their self-efficacy, as well as how to emotionally respond. The relationship and psychological bonds people with cancer and their family caregivers develop with technology during treatment may be critically important for oncology nurses to be aware of should digital health be prescribed within the outpatient model of cancer care. This study indicates that technology may not be needed for a full treatment experience, as digital health can promote confidence and self-efficacy regarding symptom management and prepare people with cancer to be independent after the digital health technology is returned to the research team. However, further research is needed regarding individual preferences for digital health provision.

Identifiants

pubmed: 38342642
pii: S0749-2081(24)00008-1
doi: 10.1016/j.soncn.2024.151587
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151587

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Andrew Darley (A)

Assistant Professor, School of Nursing, Midwifery and Health Systems, University College Dublin, Ireland. Electronic address: andrew.darley@ucd.ie.

Eileen Furlong (E)

Associate Professor, School of Nursing, Midwifery and Health Systems, University College Dublin, Ireland.

Roma Maguire (R)

Professor, Department of Computing and Information Sciences, University of Strathclyde, Glasgow, United Kingdom.

Lisa McCann (L)

Senior Lecturer, Department of Computing and Information Sciences, University of Strathclyde, Glasgow, United Kingdom.

Barbara Coughlan (B)

Associate Professor, School of Nursing, Midwifery and Health Systems, University College Dublin, Ireland.

Classifications MeSH